Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple Sclerosis
Clinical trial NCT04595045 · COMPLETED
Trial details
- NCT number
- NCT04595045
- Sponsor
- Aránzazu Vázquez Doce
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2022-07-28
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.